In the latest trading session, 1.71 million BioRestorative Therapies Inc (NASDAQ:BRTX) shares changed hands as the company’s beta touched 63.72. With the company’s most recent per share price at $1.68 changing hands around $0.08 or 5.00% at last look, the market valuation stands at $11.62M. BRTX’s current price is a discount, trading about -51.79% off its 52-week high of $2.55. The share price had its 52-week low at $1.03, which suggests the last value was 38.69% up since then.
BioRestorative Therapies Inc (NASDAQ:BRTX) trade information
Instantly BRTX is in green as seen in intraday trades today. With action -15.79%, the performance over the past five days has been red. The company’s shares are showing year-to-date upside of 17.48%, with the 5-day performance at -15.79% in the red. However, in the 30-day time frame, BioRestorative Therapies Inc (NASDAQ:BRTX) is -27.59% down.
BioRestorative Therapies Inc (BRTX) estimates and forecasts
Year-over-year growth is forecast to reach 471.33% up from the last financial year.
Consensus estimates given by 2 financial analysts project the company’s revenue in the current quarter to hit an average of 475k. 2 analysts are of the opinion that BioRestorative Therapies Inc’s revenue for the current quarter will be 628k. The company’s revenue for the corresponding quarters a year ago was 19.3k and 35k respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 2,361.14%. The estimates for the next quarter sales put growth at 1,694.29%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 79.34%. The 2025 estimates are for BioRestorative Therapies Inc earnings to increase by 58.87%, but the outlook for the next 5-year period is at 33.74% per year.
BioRestorative Therapies Inc (NASDAQ:BRTX)’s Major holders
STONEX GROUP INC. holds the second largest percentage of outstanding shares, with 0.751% or 50100.0 shares worth $0.1 million as of 2024-06-30.
Among Mutual Funds, the top two as of Dec 31, 2024 were Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund. With 29.11 shares estimated at $50360.0 under it, the former controlled 3.34% of total outstanding shares. On the other hand, Vanguard Extended Market Index Fund held about 2.35% of the shares, roughly 20.47 shares worth around $35416.0.
